Transce3nd, LLC Bristol Myers Squibb CO Transaction History
Transce3nd, LLC
- $224 Billion
- Q1 2025
A detailed history of Transce3nd, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Transce3nd, LLC holds 13 shares of BMY stock, worth $615. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13
Previous 484
97.31%
Holding current value
$615
Previous $27.9 Million
97.13%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding BMY
# of Institutions
2,795Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$9.06 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.51 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.12 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.49 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.15 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $101B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...